Sotera Health Co
NASDAQ:SHC

Watchlist Manager
Sotera Health Co Logo
Sotera Health Co
NASDAQ:SHC
Watchlist
Price: 13.61 USD 2.1% Market Closed
Market Cap: 3.9B USD
Have any thoughts about
Sotera Health Co?
Write Note

Gross Margin
Sotera Health Co

54.4%
Current
55%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
54.4%
=
Gross Profit
745.1m
/
Revenue
1.4B

Gross Margin Across Competitors

Country US
Market Cap 3.9B USD
Gross Margin
54%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 202.3B USD
Gross Margin
41%
Country US
Market Cap 166.6B USD
Gross Margin
60%
Country KR
Market Cap 66.8T KRW
Gross Margin
49%
Country CH
Market Cap 38.4B CHF
Gross Margin
29%
Country US
Market Cap 38.8B USD
Gross Margin
55%
Country US
Market Cap 36.3B USD
Gross Margin
35%
Country US
Market Cap 27B USD
Gross Margin
59%
Country US
Market Cap 24.1B USD
Gross Margin
35%
Country CN
Market Cap 162.8B CNY
Gross Margin
40%
No Stocks Found

Sotera Health Co
Glance View

Market Cap
3.9B USD
Industry
Life Sciences Tools & Services

Nestled in the heart of the life sciences industry, Sotera Health Co. emerges as a pivotal player, ensuring safety where health meets innovation. The company's journey is one of dedication to safeguarding global health, primarily through its trio of core businesses: Sterigenics, Nordion, and Nelson Labs. With a focus on sterilization, gamma technology, and laboratory testing, these subsidiaries collectively empower Sotera Health to command a critical niche in the health sector. Sterigenics steps into the spotlight by providing sterilization solutions that employ cutting-edge methodologies, such as ethylene oxide and gamma irradiation, essential for decontaminating medical equipment and consumables. Nordion complements this by leading the charge in gamma technologies, offering isotopes that are vital not just for sterilization but also in cancer treatment. Meanwhile, Nelson Labs rounds off the triad by delivering extensive microbiological and analytical testing services, catering to the rigorous standards of medical device manufacturers and pharmaceutical companies globally. The company doesn't operate in isolation; instead, it forms an integral part of the healthcare supply chain. By ensuring that surgical instruments are free of pathogens and that various health products meet stringent safety standards, Sotera Health becomes indispensable to hospitals, clinics, and research facilities around the world. Financially, the revenue streams flow predominantly from multi-year contracts and long-term client relationships, which are testament to the critical value the company provides. As the medical landscape evolves, with increasing complexity and regulatory demands, Sotera Health's blend of technology, reliability, and compliance positions it not just as a vendor, but as a protector of public health. This role orchestrates a business model that not only thrives on the present-day needs but is poised for growth as global health and safety requirements expand.

SHC Intrinsic Value
20.37 USD
Undervaluation 33%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
54.4%
=
Gross Profit
745.1m
/
Revenue
1.4B
What is the Gross Margin of Sotera Health Co?

Based on Sotera Health Co's most recent financial statements, the company has Gross Margin of 54.4%.